C000245561 Holdings — Amplify Treatments, Testing and Advancements ETF
All 56 reported holdings of Amplify Treatments, Testing and Advancements ETF (C000245561) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Alnylam Pharmaceuticals Inc | 10.34% | $955.23K |
| First American Government Obli | 9.96% | $919.61K |
| Labcorp Holdings Inc | 6.52% | $601.98K |
| Quest Diagnostics Inc | 6.10% | $563.26K |
| BioNTech SE | 5.02% | $463.28K |
| Moderna Inc | 4.88% | $450.54K |
| Vaxcyte Inc | 4.41% | $407.53K |
| ImmunityBio Inc | 4.40% | $406.09K |
| Bio-Rad Laboratories Inc | 4.00% | $369.79K |
| Zai Lab Ltd | 3.86% | $356.91K |
| Dynavax Technologies Corp | 3.48% | $321.46K |
| Immunocore Holdings PLC | 3.36% | $310.64K |
| QuidelOrtho Corp | 3.31% | $305.29K |
| BioCryst Pharmaceuticals Inc | 3.02% | $278.93K |
| Vir Biotechnology Inc | 2.87% | $264.82K |
| Novavax Inc | 2.74% | $253.34K |
| OPKO Health Inc | 2.06% | $190.53K |
| CureVac NV | 1.81% | $166.78K |
| HilleVax Inc | 1.70% | $157.24K |
| Arcturus Therapeutics Holdings | 1.55% | $143.42K |
| Fulgent Genetics Inc | 1.39% | $128.39K |
| Arbutus Biopharma Corp | 1.38% | $127.53K |
| SIGA Technologies Inc | 1.28% | $118.05K |
| Adaptive Biotechnologies Corp | 1.26% | $116.67K |
| Invesco Government & Agency Po | 1.24% | $114.63K |
| Eli Lilly & Co | 0.95% | $87.82K |
| Gilead Sciences Inc | 0.95% | $87.61K |
| Ocugen Inc | 0.94% | $87.24K |
| Regeneron Pharmaceuticals Inc | 0.92% | $85.13K |
| AbbVie Inc | 0.90% | $83.02K |
| Johnson & Johnson | 0.88% | $81.41K |
| Abbott Laboratories | 0.88% | $81.26K |
| Sanofi SA | 0.87% | $79.91K |
| Pfizer Inc | 0.86% | $79.21K |
| AstraZeneca PLC | 0.85% | $78.69K |
| Emergent BioSolutions Inc | 0.85% | $78.16K |
| Takeda Pharmaceutical Co Ltd | 0.84% | $77.96K |
| Merck & Co Inc | 0.84% | $77.38K |
| Gsk PLC | 0.82% | $75.58K |
| OraSure Technologies Inc | 0.75% | $68.91K |
| Atea Pharmaceuticals Inc | 0.66% | $60.97K |
| Enanta Pharmaceuticals Inc | 0.65% | $60.08K |
| Renovaro Inc | 0.62% | $57.24K |
| CorMedix Inc | 0.56% | $52.06K |
| Inovio Pharmaceuticals Inc | 0.50% | $46.43K |
| XBiotech Inc | 0.38% | $34.72K |
| Invivyd Inc | 0.32% | $29.10K |
| Vaxart Inc | 0.28% | $26.17K |
| InflaRx NV | 0.25% | $22.72K |
| Chimerix Inc | 0.19% | $17.41K |
| Gritstone bio Inc | 0.16% | $14.88K |
| AN2 Therapeutics Inc | 0.15% | $14.22K |
| CEL-SCI Corp | 0.15% | $13.93K |
| Cue Biopharma Inc | 0.14% | $13.37K |
| AstraZeneca PLC | 0.00% | $0 |
| Gurnet Point Capital LLC | 0.00% | $0 |
C000245561 overview: performance, fees, allocation and SEC filings